Sales Ended

Event Information

Share this event

Date and Time

Location

Location

Grand Hyatt Melbourne

123 Collins Street

Melbourne, VIC 3000

Australia

View Map

Event description

Description

With more than 8000 women in Australia currently living with ovarian cancer there is a lot of research still needed to ensure they receive the best possible treatments and outcomes. You are invited to find out about the latest research in ovarian cancer treatment from two of Australia’s leading ovarian cancer researchers. You will also have an opportunity to hear from a woman who is participating in a clinical trial, and find out about a new program empowering women who have ovarian cancer to improve outcomes for future generations.

Saturday April 1st, 2017

2.30 pm till 4.30 pm (Registration from 2.00 pm)

The Mayfair Room, Grand Hyatt Melbourne, 123 Collins St, Melbourne, VIC

  • Immunotherapy as an Ovarian Cancer Treatment | Dr Tarek Meniawy, Medical Oncologist and Clinical Senior Lecturer, University of Western Australia

  • Finding New Cancer Treatments & the Importance of Clinical Trials| Associate Professor Linda Mileshkin, Medical Oncologist and Clinical Researcher, Peter MacCallum Cancer Centre

  • Participating in a Clinical Trial | Ms Emma Burt

  • Survivors Teaching Students: Saving Women’s Lives | Dr Bronwyn Grout, ovarian cancer survivor


Dr Tarek Meniawy, Medical Oncologist and Clinical Senior Lecturer, University of Western Australia

Speaking On

Immunotherapy as an Ovarian Cancer Treatment

"There's a new weapon in the fight against cancer and it comes from your own body. Immunotherapy is treatment that uses a person's own immune system to destroy or slow the growth and spread of cancer cells. Dr Meniawy will present the current evidence for immunotherapy for ovarian cancer, how its use is being optimised through current and future clinical trials, combining immunotherapy with other anti-cancer treatments and personalised medicine to improve outcomes"

Dr Meniawy completed his medical degree at Cairo University, before undertaking postgraduate physician training at the Princess Alexandra Hospital in Brisbane. He then undertook further training in Medical Oncology at Royal Perth Hospital and Sir Charles Gairdner Hospital, before being awarded the Fellowship of the Royal Australasian College of Physicians in 2011. More recently, he has been awarded a Doctor of Philosophy (PhD) degree by the University of Western Australia, where he studied the effects of anti-cancer therapies on the immune system.

Dr Meniawy has a keen interest in teaching and research, particularly in the field of cancer immunology and immunotherapy. He is actively involved in clinical trials, acting as a Principal Investigator or co-investigator more than 20 active studies, including early trials of novel targeted therapies and immunotherapies in different tumour types, large multi-national trials in gynaecological cancers and melanoma, as well as grant-funded, investigator-initiated research. His work was published in a number of original articles in peer-reviewed journals, book chapters and conference papers, and has presented regularly at local, national and international conferences.

Associate Professor Linda Mileshkin, Medical Oncologist and Clinical Researcher, Peter MacCallum Cancer Centre, Melbourne

Speaking On

Finding New Cancer Treatments

"Virtually every advance in cancer survival has been made on the back of clinical trials. Clinical trials are recognised as the best way to introduce new cancer treatments into clinical practice. Dr Mileshkin will provide insights into how clinical trials come about from concept to funding, how they are designed and the difference types, what’s involved in participating in a clinical trial, what we can learn from them, and where to go to find out more."

Subsequent to training in medical oncology, A/Prof Mileshkin has completed a Masters of Bioethics as well as a translational research fellowship examining the role of predictive and prognostic factors in patients treated with thalidomide for multiple myeloma. Subsequently she has continued to expand her research portfolio and is currently involved in multiple clinical research projects involving people with gynaecological and lung cancers, plus carcinoma of unknown primary (CUP), as well as phase I trials in multiple tumour types.

Her current research focuses on: 1. Early and late phase clinical trials testing novel therapies for cancer 2. The supportive care of people affected by cancer. She is the international study chair for an international Australia-led government funded phase 3 trial of adjuvant therapy in locally advanced cervical cancer, as well as the principal investigator for multiple local and national trials.

Two women who have been affected by ovarian cancer will also speak about their experience of participating in a clinical trial and about ANZGOG's "Survivors Teaching Students" program.

The venue is easily accessed via public transport; Tram Stop 7/101 Collins St on the 11, 12, 48 and 109 lines and Parliament station. Parking is available in the Wilson car park attached to the Grand Hyatt at a cost $15 a day.

For more information on this event please contact OCA via email (support@ovariancancer.net.au) or phone 1300 660 334.

Date and Time

Location

Grand Hyatt Melbourne

123 Collins Street

Melbourne, VIC 3000

Australia

View Map

Save This Event

Event Saved